4//SEC Filing
BIOSPECIFICS TECHNOLOGIES CORP 4
Accession 0001062993-16-012532
CIK 0000875622operating
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 5:15 PM ET
Size
6.7 KB
Accession
0001062993-16-012532
Insider Transaction Report
Form 4
Wegman Thomas
DirectorPresident10% Owner
Transactions
- Sale
Common Stock, $.001 par value
2016-11-28$48.04/sh−11,055$531,048→ 964,824 total - Sale
Common Stock, $.001 par value
2016-11-29$48.32/sh−8,945$432,188→ 955,879 total
Footnotes (2)
- [F1]The selling price of $48.0369 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $47.50 to $49.40. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- [F2]The selling price of $48.3161 is reflective of the weighted average sale price of all transactions reported on this line. The prices for the transactions reported on this line range from $48.25 to $48.77. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Issuer
BIOSPECIFICS TECHNOLOGIES CORP
CIK 0000875622
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875622
Filing Metadata
- Form type
- 4
- Filed
- Nov 28, 7:00 PM ET
- Accepted
- Nov 29, 5:15 PM ET
- Size
- 6.7 KB